Eckert & Ziegler Strahlen- und Medizintechnik AG / Capital Increase
10.11.2009
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Berlin, November 10th, 2009. - The Board of Directors of Eckert & Ziegler
Strahlen- und Medizintechnik AG (ISIN DE 0005659700) resolved with the
consent of the Supervisory Board to carry out an increase in cash capital,
with a partial utilization of the approved capital in volumes of up to 1.35
million of new shares. The new shares are fully entitled to dividend for
the business year 2009. With the expected funds inflow the extension of the
Environmental Services segment are to be financed as well as any arising
acquisition opportunities.
The shareholders of the company will be granted a purchase right. Moreover,
the shareholders are offered an option to oversubscribe. Parallel to this,
the shares that have not been subscribed according to the legal
subscription right are offered to interested investors at the subscription
price within the framework of a private placement. A trade of subscription
rights via the stock exchange is not possible. The new shares will not be
permitted to be traded on the regulated market until further notice so that
no stock market trading will take place. The company intends to effect the
listing of the new shares to become effective on 01-31-2010. BankM,
representation of the biw Bank für Investments und Wertpapiere AG, has been
commissioned with monitoring the capital increase.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
It is intended to use the influx of funds from the capital increase
particularly for the extension of the Environmental Services segment and
for additional acquisitions of companies. The Environmental Services
segment, which was added in early 2009 with the acquisition of Nuclitec
GmbH, deals with the safe disposal of low- and medium-level radioactive
waste. 'With the beginning of operation of Schacht Konrad, a billion euro
market is being created here. The retrieval of radioactive waste from the
pit at Asse alone causes costs amounting to 0.9 to 3.7 billion EUR. We are
hopeful that we can participate in the project with our 'Competence Center
for Safe Waste Disposal GmbH' ('Kompetenzzentrum für sichere Entsorgung
GmbH'), which is a spin-off of Nuclitec', Dr. Andreas Eckert, Chief
Executive Officer of Eckert & Ziegler AG explains. The Competence Center
has the experience and in particular the infrastructure for the
conditioning of Konrad containers and it has a special approval for the
transport of radioactive waste in Germany across the borders of federal
states. It is planned to invest some 10 million EUR in the extension of
capacities to be able to cover the existing and the expected demand. To be
able to actively participate in the consolidation in the business segments
Industry and Therapy and to pursue the international expansion, existing
and future acquisition opportunities shall be used increasingly. Eckert &
Ziegler AG focuses on cutting edge technologies in the field of
radioisotopes, and with a head count of about 520 employees it is one of
the largest manufacturers in the world of radioactive components for the
science, medicine and industry sectors. The company expects sales of EUR
100 million and earnings per share of about EUR 1.80 for the current year.
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112
E-Mail: karolin.riehle@ezag.de, www.ezag.de
10.11.2009 Financial News distributed by DGAP. Medienarchiv at |[![CDATA[|[a href="http://www.dgap-medientreff.de"|]www.dgap-medientreff.de|[/a|]]]|] and |[![CDATA[|[a href="http://www.dgap.de"|]www.dgap.de|[/a|]]]|]
---------------------------------------------------------------------------
Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Deutschland
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700, DE000A0L1L69
WKN: 565970, A0L1L6
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Düsseldorf, Hamburg
End of News DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Eckert & Ziegler resolves capital increase
| Source: EQS Group AG